1,2,3,6,-tetrahydro-1- nitroso4-picoline

Also known as: Tofacitinib Nitrosamine Impurities or nitrosamine impurities of Tofacitinib
Product Name 1,2,3,6,-tetrahydro-1- nitroso4-picoline
Alternate Names Tofacitinib Impurities, Impurities of Tofacitinib
CAT No. CS-O-45591
CAS No. 89600-66-8
Category Impurities
Stock Enquire
Mol. Wt. 126.16 g/mol
Mol. For. C6H10N2O
Hazardous This is not a Hazardous Compound
COA View Sample COA
MSDS View Sample MSDS
Parent API Tofacitinib
Controlled No
Shipping Free for purchase above 1000$
Delivery In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries.
Return Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product).
Ordering Place your order online or by email sales@clearsynth.com
1,2,3,6-tetrahydro-1-nitroso-4-picoline is a chemical compound that is primarily used in the pharmaceutical industry as a building block for the synthesis of various drugs. It is a heterocyclic compound that contains a six-membered ring consisting of four carbon atoms and two nitrogen atoms. The compound is a pale yellow solid that is sparingly soluble in water, but soluble in most organic solvents. The chemical formula of 1,2,3,6-tetrahydro-1-nitroso-4-picoline is C7H9N3O2, and it has a molecular weight of 167.17 g/mol. The compound has a melting point of 85-87°C and a boiling point of 289-291°C. It is a stable compound that is not easily decomposed under normal conditions. In terms of its chemical properties, 1,2,3,6-tetrahydro-1-nitroso-4-picoline is a nitroso compound, which means it contains a nitroso functional group (-NO). This group makes the compound a potential mutagen and carcinogen, and it can react with various nucleophiles such as thiols and amines. Overall, 1,2,3,6-tetrahydro-1-nitroso-4-picoline is an important compound in the pharmaceutical industry due to its usefulness as a building block for the synthesis of various drugs. However, its potential mutagenic and carcinogenic properties should be taken into consideration when handling and using this compound.

Related Compounds

Tofacitinib Related Compound 29 | N-Nitroso Tofacitinib Amine Impurity | Tofacitinib impurity J | Tofacitinib impurity G | Tofacitinib Nitroso Impurity 2 | Tofacitinib Impurity 36 | Tofacitinib Nitroso Impurity | TOFACITINIB IMPURITY TOF-IV | Tofacitinib Related Compound 26 HCl | Tofacitinib impurity P | Tofacitinib impurity T | Tofacitinib Nitroso Impurity 5 | Tofacitinib Dihydro Impurity | Tofacitinib related compound 6 | Tofacitinib impurity K | Tofacitinib Dihydro Citricacid salt impurity | N-methyl-N-(4-methylpyridin-3-yl)nitrous amide | Tofacitinib S,S Isomer | Tofacitinib N-oxide | Tofacitinib Diastereomer | Tofacitinib Impurity (N-Des-(2-Cyanide-acetyl)-(3S,4R)) | Tofacitinib impurity N | N-methyl-N-(4-methyl-1-nitrosopiperidin-3-yl)nitrous amide | Tofacitinib Impurity 57 | Tofacitinib N- acid Impurity | Tofacitinib Diastereomer-1 and 2 | Tofacitinib- Keto Impurity | N,4-dimethyl-1-nitrosopiperidin-3-amine | N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide | Tofacitinib N-hydroxy impurity | Tofacitinib Nitroso Impurity 4 | Tofacitinib Nitroso Impurity 1 | Tofacitinib Hydroxy Impurity | Tofacitinib Impurity 6 | Tofacitinib Impurity 29 | Tofacitinib impurity C | Tofacitinib formyl impurity | Tofacitinib impurity I | Tofacitinib Impurity 16 | Tofacitinib N-Nitroso benzyl intermediate | N-methyl-N-(4-methylpiperidin-3-yl)nitrous amide | Tofacitinib impurity V | Tofacitinib impurity Z | Tofacitinib butyl ester impurity | Tofacitinib Nitroso Impurity 3 |

This page contains information about 1,2,3,6,-tetrahydro-1- nitroso4-picoline. You can buy 1,2,3,6,-tetrahydro-1- nitroso4-picoline from Clearsynth at best competitive price with assured price guarantee. Clearsynth offers best quality 1,2,3,6,-tetrahydro-1- nitroso4-picoline. This compound is also referred as Tofacitinib nitrosamine impurities or nitrosamine impurities of Tofacitinib